Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
SINOPEC CORP
00386
| (FY)Dec 31, 2025 | (Q4)Dec 31, 2025 | (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -9.74%1.04M | 80.51%259.79K | -35.29%266.7K | -29.15%256.18K | 9.51%259.18K | -5.66%1.15M | -63.45%143.92K | 4.33%412.12K | 105.38%361.6K | -8.52%236.66K |
| Net income from continuing operations | -181.49%-327.86K | -445.66%-657.7K | -89.89%10.48K | 42.92%103.71K | 501.61%215.65K | 14.65%402.34K | 503.26%190.28K | -40.90%103.66K | -34.22%72.56K | -68.11%35.85K |
| Operating gains losses | 1,531.36%807.88K | 455.70%779.62K | 1,203.79%49.23K | -132.07%-5.65K | -110.85%-15.34K | -290.14%-56.44K | -693.84%-219.18K | 256.81%3.78K | 830.72%17.6K | 5,970.51%141.36K |
| Depreciation and amortization | 47.22%9.68K | --0 | --0 | --0 | 1,409.83%9.68K | 143.84%6.57K | 797.23%3.53K | -4.80%1.77K | -5.04%640 | -4.90%641 |
| Unrealized gains and losses of investment securities | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 |
| Remuneration paid in stock | 560.80%76.77K | --0 | ---- | ---- | ---- | -26.16%11.62K | --0 | --11.62K | --0 | --0 |
| Deferred tax | -125.01%-34.19K | ---- | ---- | ---- | ---- | 12.00%136.69K | ---- | ---- | ---- | ---- |
| Other non cashItems | 30.64%792.31K | -3.94%156.9K | 18.75%236.24K | 54.07%195.24K | 73.56%203.93K | 7.08%606.49K | 11.53%163.33K | 40.97%198.94K | -9.38%126.72K | -15.47%117.5K |
| Change In working capital | -701.19%-282.74K | 111.60%15.16K | -214.80%-106.03K | -125.76%-37.12K | -163.68%-154.75K | -64.75%47.03K | -196.55%-130.72K | 17.81%92.36K | 297.32%144.07K | -698.82%-58.69K |
| -Change in receivables | -1,280.41%-30.07K | 3,794.74%87.16K | -1,570.51%-118.17K | 1,380.76%168.64K | -28,474.96%-167.7K | 126.14%2.55K | -107.56%-2.36K | -175.74%-7.07K | -40.38%11.39K | 100.85%591 |
| -Change in prepaid assets | -130.02%-19.02K | ---- | ---- | --0 | -5,863.44%-39.25K | 1,169.86%63.36K | ---- | ---- | --47.83K | 101.87%681 |
| -Change in payables and accrued expense | -1,137.97%-233.65K | -391.50%-78.65K | 94.83%-1.43K | -342.50%-205.76K | 187.04%52.19K | -112.66%-18.87K | -121.74%-16K | -140.20%-27.76K | 192.11%84.85K | -160.85%-59.96K |
| -Change in other working capital | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --127.2K | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -9.74%1.04M | 80.51%259.79K | -35.29%266.7K | -29.15%256.18K | 9.51%259.18K | -5.66%1.15M | -63.45%143.92K | 4.33%412.12K | 105.38%361.6K | -8.52%236.66K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -57.54%-1.03M | 146.73%150K | -1,707.59%-1.18M | 0 | 0 | -136.49%-652.61K | -16.32%-321K | -65.18K | 0 | -266.43K |
| Net PPE purchase and sale | --0 | --0 | ---- | ---- | ---- | ---44.18K | --0 | ---- | ---- | ---- |
| Net investment property transactions | -104.52%-950K | 146.73%150K | ---1.1M | --0 | --0 | -159.47%-464.49K | -79.32%-321K | --0 | --0 | ---143.49K |
| Net other investing changes | 45.74%-78.1K | --0 | ---- | ---- | ---- | -48.49%-143.94K | --0 | ---21K | --0 | ---122.94K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -57.54%-1.03M | 146.73%150K | -1,707.59%-1.18M | --0 | --0 | -136.49%-652.61K | -16.32%-321K | ---65.18K | --0 | ---266.43K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 100.12%291 | -336.30%-383.99K | 395.38%926.63K | 16.02%-269.83K | -214.08%-272.53K | 75.53%-233.62K | 233.10%162.5K | 19.86%-313.71K | -69.20%-321.31K | 195.13%238.89K |
| Net issuance payments of debt | 152.50%449.09K | -367.91%-349.98K | 819.10%1M | 47.36%-96.32K | -128.50%-105.26K | 135.41%177.86K | 2,004.61%130.63K | 47.85%-139.15K | -52.19%-182.97K | 404.10%369.35K |
| Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Interest paid (cash flow from financing activities) | -29.31%-744.8K | 10.86%-116K | -54.51%-272.02K | -31.70%-183.5K | -32.82%-173.27K | 3.80%-575.98K | -1.43%-130.13K | -34.30%-176.06K | 33.55%-139.33K | -0.61%-130.46K |
| Net other financing activities | 79.94%296K | -49.38%82K | 13,100.00%198K | --10K | --6K | 12.29%164.5K | --162K | -76.92%1.5K | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 100.12%291 | -336.30%-383.99K | 395.38%926.63K | 16.02%-269.83K | -214.08%-272.53K | 75.53%-233.62K | 233.10%162.5K | 19.86%-313.71K | -69.20%-321.31K | 195.13%238.89K |
| Net cash flow | ||||||||||
| Beginning cash position | 88.73%-34.05K | -135.27%-45.82K | -15.81%-61.05K | 49.03%-47.41K | 88.73%-34.05K | -2.36%-302.13K | 93.46%-19.48K | 82.51%-52.71K | 67.66%-93.01K | -2.36%-302.13K |
| Current changes in cash | -94.76%14.04K | 277.04%25.81K | -54.19%15.23K | -133.86%-13.64K | -106.39%-13.35K | 3,941.70%268.07K | -240.48%-14.58K | 829.94%33.24K | 391.13%40.29K | 2,662.86%209.12K |
| End cash Position | 41.22%-20.02K | 41.22%-20.02K | -135.27%-45.82K | -15.81%-61.05K | 49.03%-47.41K | 88.73%-34.05K | 88.73%-34.05K | 93.46%-19.48K | 82.51%-52.71K | 67.66%-93.01K |
| Free cash from | -6.15%1.04M | 80.51%259.79K | -27.52%266.7K | -29.15%256.18K | 9.51%259.18K | -9.27%1.11M | -63.45%143.92K | -6.85%367.95K | 105.38%361.6K | -8.52%236.66K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.